Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter and Canadian Researchers to Co-Develop Tests for Transplantation

NEW YORK, April 6 (GenomeWeb News) - Beckman Coulter and the Research in Immune Tolerance and Transplantation program, a $10-million initiative funded by the Canadian government and others, will jointly conduct research to develop tests for use in transplantation, the company said today.


Under the two-year agreement, Beckman will support a postdoctoral scientist, provide funding for new reagent combinations, sponsor symposiums and workshops, and help the RITT program to secure additional funding.


In return, Beckman will receive first rights to new discoveries resulting from the collaboration. RITT will also acquire over $1 million worth of separation and analysis equipment from Beckman.


The research will be conducted at the RITT Industrial Biodevelopment Laboratory at the Toronto General Hospital in Canada.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.